Rare earth nanoprobes for optical imaging and disease tracking (C3i)
用于光学成像和疾病追踪的稀土纳米探针 (C3i)
基本信息
- 批准号:10663617
- 负责人:
- 金额:$ 15.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-15 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AMD3100Administrative SupplementAlbuminsAnimal ModelAnimalsBehaviorBiological AssayBiological MarkersBody WeightCXCR4 geneCancer ModelClinical TrialsContrast MediaDataDiseaseDisseminated Malignant NeoplasmDrug KineticsElementsEncapsulatedErbiumEthanolExhibitsFluorescence-Activated Cell SortingFutureGlutaralHumanImageIn VitroIndividualKnowledgeLigandsLightLiquid substanceMeasurementMetabolicMethodsMicrofluidic MicrochipsMicrofluidicsMusNational Institute of Biomedical Imaging and BioengineeringOutputParentsPerformancePhasePlanet EarthPolymersProcessProductionPropertyProteinsReactionResearchSerum AlbuminShort WavesSignal TransductionStreamSurfaceTechniquesTechnologyTimeTumor Markersbiomaterial compatibilitychemokine receptorcommercializationcontrast imagingcrosslinkexperimental studyfluorescence-guided surgeryin vivoinstrumentationlight scatteringmouse modelnanoparticlenanoprobenephelometryoptical emissionoptical imagingoverexpressionparent grantprogramsprototyperesidencescale upsmall moleculetargeted biomarker
项目摘要
PROJECT SUMMARY / ABSTRACT
This project is a C3i Accell administrative supplement to our ongoing R01 project (EB018358 “Rare-earth nanoprobes for
optical imaging and disease tracking”). The parent R01 project is developing short-wave infrared (SWIR) light-emitting
nanoparticle contrast agents and imaging instrumentation for use in fluorescence-guided surgery. In the R01 project,
mouse models of cancer are employed to evaluate the performance of these contrast agents in vivo.
Through the core C3i program, we learned that successful commercialization of this technology will require us to
demonstrate that contrast agent synthesis can be scaled to much larger volumes than used in our R01 murine studies,
while maintaining quality and consistency. We currently synthesize nanoprobes in individual 15 ml batches which are
sufficient to complete a typical longitudinal murine experiment, but inadequate for moving the technology forward into
large animal models and in-human clinical trials. To enable these future studies, this C3i Accell project will develop and
validate methods to synthesize nanoprobes at the 1000 ml scale. Nanoprobes will contain an erbium-doped nanoparticle
core providing SWIR optical emissions, encapsulated in human serum albumin for biocompatibility, with the small
molecule AMD3100 conjugated to the outer surface for targeting the CXCR4 tumor biomarker. To maintain uniformity in
nanoprobe properties at this scale and to demonstrate a scalable approach for commercial production, we will develop
synthesis methods using a continuous flow microfluidic platform.
项目摘要/摘要
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Surface-Modified Shortwave-Infrared-Emitting Nanophotonic Reporters for Gene-Therapy Applications.
- DOI:10.1021/acsbiomaterials.8b00378
- 发表时间:2018-07-09
- 期刊:
- 影响因子:5.8
- 作者:Zhao Z;Kantamneni H;He S;Pelka S;Venkataraman AS;Kwon M;Libutti SK;Pierce M;Moghe PV;Ganapathy V;Tan MC
- 通讯作者:Tan MC
Bioadsorption of Rare Earth Elements through Cell Surface Display of Lanthanide Binding Tags.
通过细胞表面显示镧系元素结合标签来生物吸附稀土元素。
- DOI:10.1021/acs.est.5b06129
- 发表时间:2016-03-01
- 期刊:
- 影响因子:11.4
- 作者:Park DM;Reed DW;Yung MC;Eslamimanesh A;Lencka MM;Anderko A;Fujita Y;Riman RE;Navrotsky A;Jiao Y
- 通讯作者:Jiao Y
Shortwave Infrared-Emitting Theranostics for Breast Cancer Therapy Response Monitoring.
- DOI:10.3389/fmolb.2020.569415
- 发表时间:2020
- 期刊:
- 影响因子:5
- 作者:Shah JV;Gonda A;Pemmaraju R;Subash A;Bobadilla Mendez C;Berger M;Zhao X;He S;Riman RE;Tan MC;Pierce MC;Moghe PV;Ganapathy V
- 通讯作者:Ganapathy V
CXCR-4 Targeted, Short Wave Infrared (SWIR) Emitting Nanoprobes for Enhanced Deep Tissue Imaging and Micrometastatic Cancer Lesion Detection.
- DOI:10.1002/smll.201502202
- 发表时间:2015-12-16
- 期刊:
- 影响因子:0
- 作者:Zevon M;Ganapathy V;Kantamneni H;Mingozzi M;Kim P;Adler D;Sheng Y;Tan MC;Pierce M;Riman RE;Roth CM;Moghe PV
- 通讯作者:Moghe PV
Biodegradable rare earth fluorochloride nanocrystals for phototheranostics.
用于光治疗的可生物降解稀土氟氯化物纳米晶体。
- DOI:10.1039/d0ra00760a
- 发表时间:2020
- 期刊:
- 影响因子:3.9
- 作者:Zhao,Xinyu;Yu,Qi;Yuan,Jun;Thakor,NitishV;Tan,MeiChee
- 通讯作者:Tan,MeiChee
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PRABHAS V MOGHE其他文献
PRABHAS V MOGHE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PRABHAS V MOGHE', 18)}}的其他基金
Microglial-Targeted Nanotherapeutics for Inhibition of Alpha-Synuclein Aggregation and Inflammation in Neurodegenerative Diseases
抑制神经退行性疾病中α-突触核蛋白聚集和炎症的小胶质细胞靶向纳米疗法
- 批准号:
9759742 - 财政年份:2018
- 资助金额:
$ 15.48万 - 项目类别:
Nanofibrous Scaffolds for Transplantation of Human Dopaminergic Neurons
用于人类多巴胺能神经元移植的纳米纤维支架
- 批准号:
9134228 - 财政年份:2015
- 资助金额:
$ 15.48万 - 项目类别:
Nanofibrous Scaffolds for Transplantation of Human Dopaminergic Neurons
用于人类多巴胺能神经元移植的纳米纤维支架
- 批准号:
9018254 - 财政年份:2015
- 资助金额:
$ 15.48万 - 项目类别:
RARE EARTH NANOPROBES FOR OPTICAL IMAGING AND DISEASE TRACKING
用于光学成像和疾病追踪的稀土纳米探针
- 批准号:
9024524 - 财政年份:2014
- 资助金额:
$ 15.48万 - 项目类别:
RARE EARTH NANOPROBES FOR OPTICAL IMAGING AND DISEASE TRACKING
用于光学成像和疾病追踪的稀土纳米探针
- 批准号:
9236191 - 财政年份:2014
- 资助金额:
$ 15.48万 - 项目类别:
RARE EARTH NANOPROBES FOR OPTICAL IMAGING AND DISEASE TRACKING
用于光学成像和疾病追踪的稀土纳米探针
- 批准号:
8674563 - 财政年份:2014
- 资助金额:
$ 15.48万 - 项目类别:
RARE EARTH NANOPROBES FOR OPTICAL IMAGING AND DISEASE TRACKING
用于光学成像和疾病追踪的稀土纳米探针
- 批准号:
8835109 - 财政年份:2014
- 资助金额:
$ 15.48万 - 项目类别:
Albumin-Encapsulated Rare Earth Nanoprobes for Multifunctional Tissue Imaging
用于多功能组织成像的白蛋白封装稀土纳米探针
- 批准号:
8442880 - 财政年份:2012
- 资助金额:
$ 15.48万 - 项目类别:
Albumin-Encapsulated Rare Earth Nanoprobes for Multifunctional Tissue Imaging
用于多功能组织成像的白蛋白封装稀土纳米探针
- 批准号:
8285398 - 财政年份:2012
- 资助金额:
$ 15.48万 - 项目类别:
Synthetic Counter-ligands for Inhibition of Atherosclerosis
抑制动脉粥样硬化的合成反配体
- 批准号:
8087411 - 财政年份:2011
- 资助金额:
$ 15.48万 - 项目类别:
相似海外基金
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
- 批准号:
10806365 - 财政年份:2023
- 资助金额:
$ 15.48万 - 项目类别: